Genetic polymorphisms of catechol-O-methyltransferase modify the neurobehavioral effects of mercury in children

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 77, Issue 6, 2014, Pages 293-312

  Woods, James S ^a   Heyer, Nicholas J ^b   Russo, Joan E ^c   Martin, Michael D ^a   Pillai, Pradeep B ^d   Bammler, Theodor K ^a   Farin, Federico M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMALGAM; CATECHOL METHYLTRANSFERASE; MERCURY;

ALLELE; ARTICLE; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL (TOPIC); COGNITION; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTELLIGENCE QUOTIENT; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TOOTH FILLING; URINALYSIS;

CATECHOL O-METHYLTRANSFERASE; CHILD; DENTAL AMALGAM; FEMALE; HAPLOTYPES; HUMANS; MALE; MERCURY; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS;

EID: 84896287378     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2014.867210     Document Type: Article

References (46)

1. 108/158Met polymorphism on cognitive function in children. Am. J. Psychiatry 164: 142-149.
2. Barnett, J. H., Heron, J., Goldman, D., Jones, P. B., and Xu, K. 2009. Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. Am. J. Psychiatry 166: 909-916.
3. Barrett, J. C., Fry, B., Maller, J., and Daly, M. J. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. (Pubitemid 40202029)
4. Bilder, R. M., Volavka, J., Malhotra, A. K., Kennedy, J. L., Ni, X., Goldman, R. S., Hoptman, M. J., Sheitman, B., Lindenmayer, J. P., Citrome, L., McEvoy, J. P., Kunz, M., Chakos, M., Cooper, T. B., and Lieberman, J. A. 2002. Neurocognitive correlates of the COMT val158met polymorphism in chronic schizophrenia. Biol. Psychiatry 52: 701-707.
5. Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., Egan, M. F., Kleinman, J. E., and Weinberger, D. R. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in post-mortem human brain. Am. J. Hum. Genet. 75: 807-821. (Pubitemid 39390488)
6. Coccini, T., Roda, E., Castoldi, A. F., Poli, D., Goldoni, M., Vettori, M. V., Mutti, A., and Manzo, L. 2011. Developmental exposure to methylmercury and 2,2′,4,4′5,5′-hexachlorobiphenyl (PCB153) affects cerebral dopamine D1-like and D2-like receptors of weanling and pubertal rats. Arch. Toxicol. 85: 1281-1294.
7. Cohen, J., Braver, T., and Brown, J. 2002. Computational perspective on dopamine function in prefrontal cortex. Curr. Opin. Neurobiol. 12: 223-229. (Pubitemid 34518344)
8. Counter, S. A., and Buchanan, L. H. 2004. Mercury exposure in children: A review. Toxicol. Appl. Pharmacol. 198: 209-230. (Pubitemid 38952835)
9. DeRouen, T. A., Leroux, B. G., Martin, M. D., Townes, B. D., Woods, J. S., Leitão, J., Castro-Caldas, A., and Braveman N. 2002. Issues in the design and analysis of a randomized clinical trial to assess the safety of dental amalgam restorations in children. Controlled Clin. Trials 23: 301-320. (Pubitemid 34621210)
10. DeRouen, T. A., Martin, M. D., Leroux, B. G., Townes, B. D., Woods, J. S., Leitão, J., Castro-Caldas, A., Luis, H., Bernardo, M., Rosenbaum, G., and Martins, I. P. 2006. Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. J. Am. Med. Assoc. 295: 1784-1792.
11. Diamond, A. 2007. Consequences of variations in genes that affect dopamine in prefrontal cortex Cerebral Cortex 17: i161-i170.
12. Diamond, A., Briand, L., Fossella, J., and Gehlbach, L. 2004. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am. J. Psychiatry 161: 125-132. (Pubitemid 38419317)
13. Diatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Xu, K., Shabalina, S. A., Shagin, D., Max, M. B., Makarov, S. S., and Maixner, W. 2005. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet. 14: 135-143. (Pubitemid 40123469)
14. Dong, W., Bian, Y., Liang, L., and Gu, B. 2011. Binding constants of mercury and dissolved organic matter determined by a modified ion exchange technique. Environ. Sci. Technol. 45: 3576-3583.
15. 158met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition. Biol. Psychiatry 71: 538-544.
16. Faustman, E. M., Silbernagel, S. M., Fenske, R. A., Burbacher, T. M., and Ponce, R. A. 2000. Mechanisms underlying children's susceptibility to environmental toxicants. Environ. Health Perspect. 108(Suppl. 1): 13-21. (Pubitemid 30168692)
17. Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., Lui-Cordero, S. N., Rotimi, C., Adeyemo, A., Cooper, R., Ward, R., Lander, E. A., Daly, M. J., and Altshuler, D. 2002. The structure of haplotype blocks in the human genome. Science 296: 2225-2229. (Pubitemid 34680308)
18. Garris, P. A., and Wrightman, R. M. 1994. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: An in vivo voltammetric study. J. Neurosci. 14: 442-450. (Pubitemid 24022128)
19. Goldman-Rakic, P. S. 1998. The cortical dopamine system: Role in memory and cognition. Adv. Pharmacol. 42: 707-711.
20. Harrison, P. J., and Tunbridge, E. M. 2008. Catechol-O-methyltransferase (COMT): A gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 33: 3037-3045.
21. Heyer, N. J., Echeverria, D., Martin, M. D., Farin, F. M., and Woods, J. S. 2009. Catechol-O-methyltransferase (COMT) val158met functional polymorphism, dental mercury exposure, and self-reported symptoms and mood. J. Toxicol. Environ. Health A 72: 599-609.
22. Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y. M., Szumlanski, C. L., and Weinshilboum, R. M. 1996. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243-350.
23. Landrigan, P. J., and Goldman, L. R. 2011. Children's vulnerability to toxic chemicals: A challenge and opportunity to strengthen health and environmental policy. Health Affairs 30: 842-850.
24. Li, T., and Woods, J. S. 2009. Cloning, expression, and biochemical properties of CPOX4, a genetic variant of coproporphyrinogen oxidase that affects susceptibility to mercury toxicity in humans. Toxicol. Sci. 109: 228-236.
25. Makri, A., Goveia, M., Balbus, J., and Parkin, R. 2004. Children's susceptibility to chemicals: A review by developmental stage. J. Toxicol. Environ. Health B 7: 417-435. (Pubitemid 39487649)
26. Malhotra, A. K., Kestler, L.J., Mazzanti, C., Bates, T., Goldberg, T., and Goldman, D. 2002. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry 159: 652-654. (Pubitemid 34274949)
27. Martins, I. P., Castro-Caldas, A., Townes, B. D., Ferreira, G., Rodrigues, P., Marques, S., and Rosebaum, G. 2005. Age and sex differences in neurobehavioral performance: A study of Portuguese elementary school children. Int. J. Neurosci. 115: 1687-1709 (Pubitemid 43154592)
28. Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., and Weinberger, D. R. 2003. Catechol O-methyltransferase val158met genotype and individual variation in the brain response to amphetamine. Proc. Natl. Acad. Sci. USA 100: 6186-6191. (Pubitemid 36576952)
29. Mukherjee, N., Kidd, K. K., Pakstis, A.J., Speed, W. C., Li, H., Tarnok, Z., Barta, C., Kajuna, S. L. B., and Kidd, J. R. 2010. The complex global pattern on genetic variation and linkage disequilibrium at catechol-O- methyltransferase. Mol. Psychiat. 15: 216-225.
30. Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., Maixner, W., and Diatchenko, L. 2006. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314: 1930-1933. (Pubitemid 46026115)
31. Nackley, A. G., Shabalina, S. A., Lambert, J. E., Conrad, M. S., Gibson, D. G., Spiridonov, A. N., Satterfield, S. K., and Diatchenko, L. 2009. Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: Evidence for marker SNPs. PloS One 4: e5237.
32. National Center for Biotechnology Information. 2012. SNP linked to COMT SNPs via contig annotation. http://www.ncbi.nlm.nih.gov/snp/?term=rs4680, http://www.ncbi.nlm.nih.gov/snp/?term=rs4818, http://www.ncbi.nlm.nih.gov/snp/? term=rs4633, or http://www.ncbi.nlm.nih.gov/snp/?term=rs6269, respectively (accessed September 13, 2013).
33. Pingree, S. D., Simmonds, P. L., and Woods, J. S. 2001. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats. Toxicol. Sci. 61: 224-233. (Pubitemid 32499390)
34. Sherman, L. S., Blum, J. D., Franzblau, A., and Basu, N. 2013. New insight into biomarkers of human mercury exposures using naturally occurring mercury isotopes. Environ. Sci. Technol. 47: 3403-3409.
35. Stephens, M., Smith, N., and Donnelly, P. 2001. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68: 978-989. (Pubitemid 32289743)
36. Tenhunen, J., Salminen, M., Jalanko, A., Ukkonen, I., and Ulmanen, I. 1993. Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme. DNA Cell Biol. 12: 253-263. (Pubitemid 23121007)
37. Tenhunen, J., Salminen, M., Lundstrom, K., Kiviluoto, T., Savolainen, R., and Ulmanen, I. 1994. Genomic organization of the human catechol-O- methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem. 223: 1049-1059. (Pubitemid 24263190)
38. Townes, B. D., Martins, I. P., Castro-Caldas, A., Rosenbaum, G., and DeRouen, T. 2008. Repeat test scores on neurobehavioral measures over an eight-year period in a sample of Portuguese children. Int. J. Neurosci. 118: 79-93. (Pubitemid 350175304)
39. Tsuzuki, Y. 1981. Effects of chronic methylmercury exposure on activities of neurotransmitter enzymes in rat cerebellum. Toxicol. Appl. Pharmacol. 60: 379-381. (Pubitemid 11060830)
40. Tunnicliff, G., and Wood, J. D. 1973. The inhibition of mouse brain neurotransmitter enzymes by mercury compounds and a comparison with the effects of hyperbaric oxygen. Comp. Gen. Pharmacol. 4: 101-105.
41. Weinshilboum, R. M., Otterness, D. M., and Szumlanski, C. L. 1999. Methylation pharmacogenetics: Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 39: 19-52. (Pubitemid 29222550)
42. Woods, J. S., Heyer, N. J., Echeverria D., Russo, J. E., Martin, M. D., Bernardo, M. F., Luis, H. S., Vaz, L., and Farin, F. M. 2012. Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children. Neurotoxicol. Teratol. 34: 513-521.
43. Woods, J. S., Heyer, N. J., Russo, J. E., Martin, M. D., Pillai, P. B., and Farin, F. M. 2013. Modification of neurobehavioral effects of mercury by genetic polymorphisms of metallothionein in children. Neurotoxicol. Teratol. 39: 36-44.
44. Woods, J. S., Martin, M. D., Leroux, B. G., DeRouen, T. A., Leitão, J. G., Bernardo, M., Luis, H. S., Simmonds, P. L., Kushleika, J. V., and Huang Y. 2007. The contribution of dental amalgam to urinary mercury excretion in children. Environ. Health Perspect. 115: 527-1531.
45. Xie, T., Ho, S. L., and Ramsden, D. B. 1999. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol. Pharmacol. 56: 3-38.
46. Yavich, L., Porsberg, M. M., Karayiorgou, M., Gogos, J. A., and Mannisto, P. T. 2007. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J. Neurosci. 27: 10196-10209.